Phibro Operating Income from 2010 to 2024

PAHC Stock

USD 24.14 0.40 1.68%

Phibro Animal's Operating Income is increasing over the years with very volatile fluctuation. Operating Income is expected to dwindle to about 51.9 M. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Phibro Animal Health generates from its operations. View All Fundamentals

Operating Income

First Reported

2000-03-31

Previous Quarter

12.6 M

Current Value

17.7 M

Quarterly Volatility

10 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Phibro Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phibro Animal's main balance sheet or income statement drivers, such as Depreciation And Amortization of 38 M, Interest Expense of 18.1 M or Selling General Administrative of 139.2 M, as well as many indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0277 or PTB Ratio of 3.21. Phibro financial statements analysis is a perfect complement when working with Phibro Animal Valuation or Volatility modules.

Check out the analysis of Phibro Animal Correlation against competitors.

Latest Phibro Animal's Operating Income Growth Pattern

Below is the plot of the Operating Income of Phibro Animal Health over the last few years. Operating Income is the amount of profit realized from Phibro Animal Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Phibro Animal Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Phibro Animal's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phibro Animal's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Phibro Operating Income Regression Statistics

	Arithmetic Mean	62,149,363
	Geometric Mean	57,003,401
	Coefficient Of Variation	38.09
	Mean Deviation	19,209,394
	Median	56,731,000
	Standard Deviation	23,675,705
	Sample Variance	560.5T
	Range	83.2M
	R-Value	0.02
	Mean Square Error	603.5T
	R-Squared	0.0003
	Significance	0.95
	Slope	94,825
	Total Sum of Squares	7847.5T

Phibro Operating Income History

	2024	51.9 M
	2023	53.3 M
	2022	71.8 M
	2021	46.3 M
	2020	43 M
	2019	36.9 M
	2018	73.3 M

Other Fundumenentals of Phibro Animal Health

Non Operating Income Net Other

Phibro Animal Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.87	0.8	0.82	0.52	0.95	0.89	0.99	0.62	0.78	-0.13	0.96	0.95	0.79	0.03	0.73	0.26	-0.69	0.73	0.78	0.86	0.82	0.82	-0.09
Total Stockholder Equity	0.81		0.53	0.98	0.54	0.24	0.84	0.54	0.8	0.78	0.65	-0.55	0.76	0.87	0.94	-0.06	0.75	0.34	-0.79	0.54	0.84	0.93	0.82	0.83	-0.39
Net Debt	0.87	0.53		0.55	0.78	0.76	0.72	0.97	0.87	0.58	0.6	0.19	0.88	0.82	0.58	0.01	0.59	0.02	-0.39	0.83	0.66	0.64	0.79	0.76	-0.14
Retained Earnings	0.8	0.98	0.55		0.52	0.33	0.79	0.54	0.78	0.84	0.6	-0.51	0.76	0.87	0.93	-0.07	0.77	0.26	-0.73	0.61	0.87	0.92	0.86	0.86	-0.42
Accounts Payable	0.82	0.54	0.78	0.52		0.54	0.81	0.88	0.86	0.46	0.54	0.17	0.72	0.7	0.62	-0.22	0.39	0.19	-0.47	0.59	0.64	0.58	0.7	0.71	-0.15
Long Term Debt	0.52	0.24	0.76	0.33	0.54		0.36	0.69	0.54	0.52	0.15	0.27	0.61	0.57	0.33	-0.02	0.38	-0.47	0.17	0.81	0.51	0.27	0.68	0.63	-0.16
Net Receivables	0.95	0.84	0.72	0.79	0.81	0.36		0.77	0.96	0.57	0.68	-0.24	0.87	0.85	0.82	-0.01	0.63	0.29	-0.69	0.57	0.76	0.83	0.78	0.81	-0.09
Total Liab	0.89	0.54	0.97	0.54	0.88	0.69	0.77		0.9	0.53	0.64	0.27	0.86	0.8	0.61	-0.03	0.55	0.11	-0.47	0.74	0.67	0.65	0.74	0.73	-0.15
Total Current Assets	0.99	0.8	0.87	0.78	0.86	0.54	0.96	0.9		0.63	0.72	-0.07	0.94	0.92	0.81	0.0	0.71	0.25	-0.66	0.71	0.8	0.83	0.84	0.84	-0.12
Short Term Debt	0.62	0.78	0.58	0.84	0.46	0.52	0.57	0.53	0.63		0.25	-0.38	0.68	0.72	0.86	-0.22	0.7	0.04	-0.43	0.73	0.92	0.73	0.9	0.88	-0.73
Intangible Assets	0.78	0.65	0.6	0.6	0.54	0.15	0.68	0.64	0.72	0.25		-0.11	0.68	0.78	0.49	0.16	0.59	0.4	-0.79	0.37	0.42	0.75	0.41	0.39	0.14
Common Stock	-0.13	-0.55	0.19	-0.51	0.17	0.27	-0.24	0.27	-0.07	-0.38	-0.11		-0.16	-0.26	-0.35	0.06	-0.26	-0.26	0.39	-0.16	-0.31	-0.36	-0.26	-0.26	0.22
Property Plant Equipment	0.96	0.76	0.88	0.76	0.72	0.61	0.87	0.86	0.94	0.68	0.68	-0.16		0.94	0.75	0.09	0.76	0.17	-0.59	0.83	0.83	0.81	0.83	0.81	-0.16
Good Will	0.95	0.87	0.82	0.87	0.7	0.57	0.85	0.8	0.92	0.72	0.78	-0.26	0.94		0.8	0.03	0.8	0.22	-0.68	0.8	0.83	0.87	0.86	0.83	-0.2
Net Tangible Assets	0.79	0.94	0.58	0.93	0.62	0.33	0.82	0.61	0.81	0.86	0.49	-0.35	0.75	0.8		-0.17	0.71	0.27	-0.68	0.54	0.91	0.89	0.87	0.9	-0.57
Current Deferred Revenue	0.03	-0.06	0.01	-0.07	-0.22	-0.02	-0.01	-0.03	0.0	-0.22	0.16	0.06	0.09	0.03	-0.17		0.0	0.05	-0.04	-0.04	-0.22	-0.03	-0.13	-0.12	0.45
Short Term Investments	0.73	0.75	0.59	0.77	0.39	0.38	0.63	0.55	0.71	0.7	0.59	-0.26	0.76	0.8	0.71	0.0		0.15	-0.57	0.57	0.78	0.75	0.66	0.64	-0.23
Deferred Long Term Liab	0.26	0.34	0.02	0.26	0.19	-0.47	0.29	0.11	0.25	0.04	0.4	-0.26	0.17	0.22	0.27	0.05	0.15		-0.74	-0.04	0.13	0.25	0.07	0.09	-0.01
Short Long Term Debt	-0.69	-0.79	-0.39	-0.73	-0.47	0.17	-0.69	-0.47	-0.66	-0.43	-0.79	0.39	-0.59	-0.68	-0.68	-0.04	-0.57	-0.74		-0.28	-0.55	-0.8	-0.47	-0.48	0.17
Long Term Debt Total	0.73	0.54	0.83	0.61	0.59	0.81	0.57	0.74	0.71	0.73	0.37	-0.16	0.83	0.8	0.54	-0.04	0.57	-0.04	-0.28		0.73	0.55	0.85	0.79	-0.28
Capital Surpluse	0.78	0.84	0.66	0.87	0.64	0.51	0.76	0.67	0.8	0.92	0.42	-0.31	0.83	0.83	0.91	-0.22	0.78	0.13	-0.55	0.73		0.82	0.88	0.88	-0.6
Long Term Investments	0.86	0.93	0.64	0.92	0.58	0.27	0.83	0.65	0.83	0.73	0.75	-0.36	0.81	0.87	0.89	-0.03	0.75	0.25	-0.8	0.55	0.82		0.76	0.77	-0.36
Net Invested Capital	0.82	0.82	0.79	0.86	0.7	0.68	0.78	0.74	0.84	0.9	0.41	-0.26	0.83	0.86	0.87	-0.13	0.66	0.07	-0.47	0.85	0.88	0.76		0.99	-0.48
Net Working Capital	0.82	0.83	0.76	0.86	0.71	0.63	0.81	0.73	0.84	0.88	0.39	-0.26	0.81	0.83	0.9	-0.12	0.64	0.09	-0.48	0.79	0.88	0.77	0.99		-0.47
Capital Stock	-0.09	-0.39	-0.14	-0.42	-0.15	-0.16	-0.09	-0.15	-0.12	-0.73	0.14	0.22	-0.16	-0.2	-0.57	0.45	-0.23	-0.01	0.17	-0.28	-0.6	-0.36	-0.48	-0.47

Click cells to compare fundamentals

About Phibro Animal Financial Statements

Phibro Animal stakeholders use historical fundamental indicators, such as Phibro Animal's Operating Income, to determine how well the company is positioned to perform in the future. Although Phibro Animal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Phibro Animal's assets and liabilities are reflected in the revenues and expenses on Phibro Animal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Phibro Animal Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	53.3 M	51.9 M
Non Operating Income Net Other	-2.8 M	-2.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Phibro Animal Correlation against competitors.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.94)

Dividend Share

0.48

Earnings Share

0.43

Revenue Per Share

25.843

Quarterly Revenue Growth

0.126

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phibro Operating Income from 2010 to 2024

Latest Phibro Animal's Operating Income Growth Pattern

Phibro Operating Income Regression Statistics

Phibro Operating Income History

Other Fundumenentals of Phibro Animal Health

Phibro Animal Operating Income component correlations

About Phibro Animal Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY